EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.23 | JZL184 | selective inhibitor | Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.23 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.23 | hepatocyte | - |
Mus musculus | - |
3.1.1.23 | liver | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.23 | 2-arachidonoylglycerol + H2O | - |
Mus musculus | glycerol + arachidonic acid | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.23 | MAGL | - |
Mus musculus |
3.1.1.23 | monoacylglycerol lipase | - |
Mus musculus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.1.1.23 | malfunction | enzyme inactivation attenuates hepatic ischemia/reperfusion-induced tissue injury, inflammation and oxidative stress | Mus musculus |
3.1.1.23 | physiological function | monoacylglycerol lipase promotes hepatic injury via endocannabinoid and eicosanoid signaling | Mus musculus |